Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study
dc.citation.issue | 3 | |
dc.citation.volume | v. 14 | |
dc.contributor.author | Skrobot, Olivia A. | |
dc.contributor.author | Black, Sandra E. | |
dc.contributor.author | Chen, Christopher | |
dc.contributor.author | DeCarli, Charles | |
dc.contributor.author | Erkinjuntti, Timo | |
dc.contributor.author | Ford, Gary A. | |
dc.contributor.author | Kalaria, Rajesh N. | |
dc.contributor.author | O'Brien, John | |
dc.contributor.author | Pantoni, Leonardo | |
dc.contributor.author | Pasquier, Florence | |
dc.contributor.author | Roman, Gustavo C. | |
dc.contributor.author | Wallin, Anders | |
dc.contributor.author | Sachdev, Perminder | |
dc.contributor.author | Skoog, Ingmar | |
dc.contributor.author | Ben-Shlomo, Yoav | |
dc.contributor.author | Passmore, Anthony P. | |
dc.contributor.author | Love, Seth | |
dc.contributor.author | Kehoe, Patrick G. | |
dc.contributor.author | Taragano, F. E. | |
dc.contributor.author | Kril, J. | |
dc.contributor.author | Cavalieri, M. | |
dc.contributor.author | Jellinger, K. A. | |
dc.contributor.author | Kovacs, G. G. | |
dc.contributor.author | Engelborghs, S. | |
dc.contributor.author | Lafosse, C. | |
dc.contributor.author | Bertolucci, Paulo Henrique Ferreira [UNIFESP] | |
dc.contributor.author | Brucki, S. | |
dc.contributor.author | Caramelli, P. | |
dc.contributor.author | Alves, T. . C. de Toledo Ferraz | |
dc.contributor.author | Bocti, C. | |
dc.contributor.author | Fulop, T. | |
dc.contributor.author | Hogan, D. B. | |
dc.contributor.author | Hsiung, G. R. | |
dc.contributor.author | Kirk, A. | |
dc.contributor.author | Leach, L. | |
dc.contributor.author | Robillard, A. | |
dc.contributor.author | Sahlas, D. J. | |
dc.contributor.author | Guo, Q. | |
dc.contributor.author | Tian, J. | |
dc.coverage | New York | |
dc.date.accessioned | 2020-07-20T16:31:20Z | |
dc.date.available | 2020-07-20T16:31:20Z | |
dc.date.issued | 2018 | |
dc.description.abstract | Introduction: Progress in understanding and management of vascular cognitive impairment (VCI) has been hampered by lack of consensus on diagnosis, reflecting the use of multiple different assessment protocols. A large multinational group of clinicians and researchers participated in a two-phase Vascular Impairment of Cognition Classification Consensus Study (VICCCS) to agree on principles (VICCCS-1) and protocols (VICCCS-2) for diagnosis of VCI. We present VICCCS-2. Methods: We used VICCCS-1 principles and published diagnostic guidelines as points of reference for an online Delphi survey aimed at achieving consensus on clinical diagnosis of VCI. Results: Six survey rounds comprising 65-79 participants agreed guidelines for diagnosis of VICCCS-revised mild and major forms of VCI and endorsed the National Institute of Neurological Disorders-Canadian Stroke Network neuropsychological assessment protocols and recommendations for imaging. Discussion: The VICCCS-2 suggests standardized use of the National Institute of Neurological Disorders-Canadian Stroke Network recommendations on neuropsychological and imaging assessment for diagnosis of VCI so as to promote research collaboration. (C) 2017 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved. | en |
dc.description.affiliation | Univ Bristol, Translat Hlth Sci, Bristol, Avon, England | |
dc.description.affiliation | Univ Toronto, Sunnybrook Res Inst, Toronto, ON, Canada | |
dc.description.affiliation | Natl Univ Singapore, Dept Pharmacol, Singapore, Singapore | |
dc.description.affiliation | Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA | |
dc.description.affiliation | Univ Calif Davis, Ctr Neurosci, Sacramento, CA 95817 USA | |
dc.description.affiliation | Univ Helsinki, Neurol, Helsinki, Finland | |
dc.description.affiliation | Helsinki Univ Hosp, Helsinki, Finland | |
dc.description.affiliation | Univ Oxford, Div Med Sci, Oxford, England | |
dc.description.affiliation | Newcastle Univ, Inst Neurosci, Newcastle, England | |
dc.description.affiliation | Univ Cambridge, Sch Clin Med, Dept Psychiat, Cambridge, England | |
dc.description.affiliation | Univ Florence, NEUROFARBA Dept, Florence, Italy | |
dc.description.affiliation | Univ Lille, INSERM, U1171, Lille, France | |
dc.description.affiliation | Methodist Neurol Inst, Houston, TX USA | |
dc.description.affiliation | Sahlgrens Univ Hosp, Memory Clin, Dept Neuropsychiat, Molndal, Sweden | |
dc.description.affiliation | Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden | |
dc.description.affiliation | Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia | |
dc.description.affiliation | Prince Wales Hosp, Neuropsychiat Inst, Randwick, NSW, Australia | |
dc.description.affiliation | Univ Bristol, Populat Hlth Sci, Bristol, Avon, England | |
dc.description.affiliation | Queens Univ Belfast, Inst Clin Sci, Block B, Belfast, Antrim, North Ireland | |
dc.description.affiliation | CONICET Natl Res Council, Buenos Aires, DF, Argentina | |
dc.description.affiliation | CEMIC Univ Hosp, Buenos Aires, DF, Argentina | |
dc.description.affiliation | Univ Sydney, Sydney, Australia | |
dc.description.affiliation | Med Univ Graz, Graz, Austria | |
dc.description.affiliation | Inst Clin Neurobiol, Graz, Austria | |
dc.description.affiliation | Med Univ Vienna, Graz, Austria | |
dc.description.affiliation | Univ Antwerp, Antwerp, Belgium | |
dc.description.affiliation | RevArte Rehabil Hosp, Antwerp, Belgium | |
dc.description.affiliation | Cathol Univ Leuven, Leuven, Belgium | |
dc.description.affiliation | Univ Fed Sao Paulo, Sao Paulo, Brazil | |
dc.description.affiliation | Univ Sao Paulo, Sao Paulo, Brazil | |
dc.description.affiliation | Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil | |
dc.description.affiliation | Dept Psychiat Sao Paulo Med Sch, Sao Paulo, Brazil | |
dc.description.affiliation | Univ Sherbrooke, Sherbrooke, PQ, Canada | |
dc.description.affiliation | Univ Calgary, Calgary, AB, Canada | |
dc.description.affiliation | Univ British Columbia, Vancouver, BC, Canada | |
dc.description.affiliation | Univ Saskatchewan, Saskatoon, SK, Canada | |
dc.description.affiliation | York Univ, Glendon Coll, York, N Yorkshire, England | |
dc.description.affiliation | Hop Maisonneuve, Montreal, PQ, Canada | |
dc.description.affiliation | McMaster Univ, Hamilton, ON, Canada | |
dc.description.affiliation | Fudan Univ, Huashan Hosp, Shanghai, Peoples R China | |
dc.description.affiliation | Beijing Univ Chinese Med, Dongzhimen Hosp, Beijing, Peoples R China | |
dc.description.affiliationUnifesp | Univ Fed Sao Paulo, Sao Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Alzheimer's Society (UK) | |
dc.description.sponsorship | Pfizer | |
dc.description.sponsorship | Athersys | |
dc.description.sponsorship | AstraZeneca | |
dc.description.sponsorship | Lundbeck | |
dc.description.sponsorship | Cerevast | |
dc.description.sponsorship | Daiichi Sankyo | |
dc.description.sponsorship | Boehringer Ingelheim | |
dc.description.sponsorship | GE Healthcare | |
dc.description.sponsorship | TauRx | |
dc.description.sponsorship | Cytox | |
dc.description.sponsorship | Avid/Lilly | |
dc.description.sponsorship | Takeda | |
dc.description.sponsorship | Eli Lilly | |
dc.description.sponsorship | Elan/Transition Therapeutics | |
dc.description.sponsorship | Roche | |
dc.description.sponsorship | Cognoptix | |
dc.description.sponsorship | Eisai | |
dc.description.sponsorship | Novartis | |
dc.description.sponsorshipID | ASUK: Ref117 | |
dc.format.extent | 280-292 | |
dc.identifier | http://dx.doi.org/10.1016/j.jalz.2017.09.007 | |
dc.identifier.citation | Alzheimers & Dementia. New York, v. 14, n. 3, p. 280-292, 2018. | |
dc.identifier.doi | 10.1016/j.jalz.2017.09.007 | |
dc.identifier.issn | 1552-5260 | |
dc.identifier.uri | https://repositorio.unifesp.br/handle/11600/55889 | |
dc.identifier.wos | WOS:000427993000003 | |
dc.language.iso | eng | |
dc.publisher | Elsevier Science Inc | |
dc.relation.ispartof | Alzheimers & Dementia | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.subject | Vascular cognitive impairment | en |
dc.subject | Vascular dementia | en |
dc.subject | Guidelines | en |
dc.subject | Criteria | en |
dc.subject | consensus | en |
dc.subject | Delphi | en |
dc.title | Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study | en |
dc.type | info:eu-repo/semantics/article |